Summit Trail Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Sell
14,758
-2,183
-13% -$24.4K ﹤0.01% 1437
2026
Q1
$183K Buy
16,941
+5,841
+53% +$50K ﹤0.01% 1381
2025
Q4
$67.8K Buy
+11,100
New +$66.3K ﹤0.01% 1298
2018
Q1
Sell
-320
Closed -$8K 1356
2017
Q4
$8K Buy
+320
New +$6.63K ﹤0.01% 1286

Other funds holding PTEN

Summit Trail Advisors's PTEN Position: Q2 2026 in Review

Summit Trail Advisors reduced its Patterson-UTI (PTEN) stake by 13% in Q2 2026, selling an estimated $24.4K and leaving 14,758 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Summit Trail Advisors first reported a position in PTEN in Q4 2017 and has held it in 4 quarters since. The position peaked at $183K in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Summit Trail Advisors held 14,758 shares of Patterson-UTI worth $135K as of Q2 2026.
  • Summit Trail Advisors sold 2,183 Patterson-UTI shares in Q2 2026, an estimated $24.4K.
  • Patterson-UTI made up ﹤0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1437 holding.
  • Summit Trail Advisors first reported a position in Patterson-UTI in Q4 2017 and has held it in 4 quarters since.
  • Summit Trail Advisors's Patterson-UTI position peaked at $183K in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.